Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

HCRN GI14-186

A Multi-Center, Single Arm, Phase II study of Pembrolizumab (MK-3475) in Combination with Chemotherapy for Patients with Advanced Colorectal Cancer: HCRN GI14-186

For full description, see www.clinicaltrials.gov.

Manuscripts/Articles:

  • CJ Herting, MR Farren, Y Tong, Z Liu, B O’Neil, T Bekaii-Saab, A Noonan, C McQuinn, TA Mace, W Shaib, C Wu, BF El-Rayes, S Shahda, GB Lesinski. A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186. Cancer Immunology, Immunotherapy (2021): https://doi.org/10.1007/s00262-021-02986-5. See abstract.

Abstracts/Posters/Presentations:

  • S Shahda, AM Noonan, TS Bekaii-Saab, BH O’Neil, A Sehdev, WL Shaib, PR Helft, PJ Loehrer, Y Tong, Z Liu, BF El-Rayes. A phase II study of pembrolizumab in combination with mFOLFOX6 for patients with advanced colorectal cancer. Accepted to Poster Session at the 2017 ASCO Annual Meeting. See abstract.